Fast, fully automated analysis of voriconazole from serum by LC-LC-ESI-MS-MS with parallel column-switching technique

被引:52
作者
Egle, H
Trittler, R
König, A
Kümmerer, K
机构
[1] Freiburg Univ Hosp, Inst Environm Med, D-79106 Freiburg, Germany
[2] Freiburg Univ Hosp, Hosp Epidemiol, D-79106 Freiburg, Germany
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2005年 / 814卷 / 02期
关键词
voriconazole; column-switching; LC-LC-ESI-MS-MS; serum; on-line sample preparation;
D O I
10.1016/j.jchromb.2004.10.069
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Voriconazole is a novel broad-spectrum antifungal agent. We developed an on-line LC-LC-MS-MS method for fully automated and direct analysis of voriconazole in raw human serum. After injection of human serum size-selective sample fractionation and analyte extraction was achieved using an extraction column (25 mm x 4 mm) packed with a restricted access material (RAM, LiChrospher(R) ADS C-8, 25 mum). On-line transfer of voriconazole from the extraction column was followed by chromatography separation on a C-18 column. Detection was done by ESI-MS-MS. The total analysis time was 13 min, managed by parallel extraction and chromatographic separation. This LC-MS assay was fully validated. The lower limit of quantification was 0.05 mug/ml. The automated inline extraction of voriconazole described here eliminates the need for difficult and time-consuming sample pre-treatment. Other advantages of the new method are that only a small quantity (5 mul) of serum is needed and that the method is very specific. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:361 / 367
页数:7
相关论文
共 36 条
[1]   In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model [J].
Andes, D ;
Marchillo, K ;
Stamstad, T ;
Conklin, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3165-3169
[2]   ALKYL-DIOL SILICA (ADS) - RESTRICTED ACCESS PRECOLUMN PACKINGS FOR DIRECT-INJECTION AND COUPLED-COLUMN CHROMATOGRAPHY OF BIOFLUIDS [J].
BOOS, KS ;
RUDOLPHI, A ;
VIELHAUER, S ;
WALFORT, A ;
LUBDA, D ;
EISENBEISS, F .
FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY, 1995, 352 (7-8) :684-690
[3]   Voriconazole: A second-generation triazole [J].
Chandrasekar, PH ;
Manavathu, E .
DRUGS OF TODAY, 2001, 37 (02) :135-148
[4]   A new, rapid, fully automated method for determination of fluconazole in serum by column-switching liquid chromatography [J].
Egle, H ;
Trittler, R ;
Kümmerer, K .
THERAPEUTIC DRUG MONITORING, 2004, 26 (04) :425-431
[5]   A new and rapid method for monitoring the new oxazolidinone antibiotic linezolid in serum and urine by high performance liquid chromatography-integrated sample preparation [J].
Ehrlich, M ;
Trittler, R ;
Daschner, FD ;
Kümmerer, K .
JOURNAL OF CHROMATOGRAPHY B, 2001, 755 (1-2) :373-377
[6]   A rapid HPLC assay for voriconazole in human plasma [J].
Gage, R ;
Stopher, DA .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 17 (08) :1449-1453
[7]   Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans [J].
Hariprasad, SM ;
Mieler, WF ;
Holz, ER ;
Gao, H ;
Kim, JE ;
Chi, JD ;
Prince, RA .
ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (01) :42-47
[8]   Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis [J].
Kirkpatrick, WR ;
McAtee, RK ;
Fothergill, AW ;
Rinaldi, MG ;
Patterson, TF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (10) :2865-2868
[9]   Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: A dose escalation study [J].
Lazarus, HM ;
Blumer, JL ;
Yanovich, S ;
Schlamm, H ;
Romero, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (04) :395-402
[10]   In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis and Histoplasma capsulatum [J].
Li, RK ;
Ciblak, MA ;
Nordoff, N ;
Pasarell, L ;
Warnock, DW ;
McGinnis, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1734-1736